Tejara Capital LTD Cardiol Therapeutics Inc. Put Options Transaction History
Tejara Capital LTD
- $153 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CRDL
# of Institutions
45Shares Held
7.56MCall Options Held
4.9KPut Options Held
3.8K-
Advisor Shares Investments LLC Bethesda, MD882KShares$891,3120.23% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$803,5810.31% of portfolio
-
Pvg Asset Management Corp Golden, CO487KShares$492,1673.54% of portfolio
-
Cambridge Investment Research Advisors, Inc.331KShares$333,8100.0% of portfolio
-
Envestnet Asset Management Inc310KShares$312,7800.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $62.6M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...